FOSUN HEALTH Logo

Colorectal Cancer Causes

catalogue

Colorectal Cancer Causes

Colorectal Cancer Causes

There is no single cause of colorectal cancer. There is a set of factors that shift the odds — some fixed, some modifiable — and one that is unusual in oncology: a precursor lesion that can be removed before it ever becomes cancer.

Age, and why this cancer has a precursor

Age is the strongest single risk factor. Incidence rises steadily from the mid-forties and continues to rise, which is why screening programmes in most countries now begin around 45 rather than 50. Being older is not a cause in itself; it is time during which the sequence of changes that turns a normal cell into a cancer cell becomes more likely to complete.

What makes colorectal cancer unusual is that this sequence has a visible intermediate stage. Most of these cancers develop from an adenomatous polyp — a growth that is not cancer, can be seen through a colonoscope, and can be removed during the same examination. That is why this is one of the few cancers that screening can prevent rather than merely detect earlier, and why the presence of polyps on a previous examination is itself a risk factor rather than a footnote.

Polyps, and what a previous polyp means

Not all polyps are equal, and what was removed in the past changes the surveillance interval that applies now.

Finding at previous examination What it implies
No polyps Average risk; continue routine screening at the standard interval
One or two small tubular adenomas A modest increase in risk; surveillance is usually brought forward but remains straightforward
Advanced adenoma — large, villous, or with high-grade dysplasia A meaningful increase in risk, justifying closer surveillance and earlier repeat examination
Multiple or repeatedly recurring adenomas Suggests a predisposition worth investigating, including consideration of genetic assessment
Sessile serrated lesions Follow a different pathway to cancer and are easily missed; surveillance intervals are adjusted accordingly

Adenoma characteristics therefore carry prognostic meaning: the number, size and histology of previous lesions determine how soon the next examination is due.

Inherited risk: a minority of cases, the highest stakes

Around one case in twenty is associated with an inherited predisposition, and identifying it changes surveillance for the patient and testing for the family.

Lynch syndrome

Caused by an inherited mismatch repair gene defect, and the commonest of the colorectal cancer syndromes. It raises the risk of colorectal cancer, often at a younger age, and also of endometrial, ovarian, urinary tract and other cancers. Because tumours in Lynch syndrome are usually mismatch repair deficient, immunotherapy is effective when cancer occurs — and family members can be tested before cancer does.

Familial adenomatous polyposis

Causes hundreds to thousands of polyps from adolescence and, without intervention, near-inevitable cancer at a young age. It is managed with early and frequent endoscopy and, in many patients, surgery to remove the colon. Because the pattern is dominant, each child of an affected parent has a one-in-two chance of inheriting it, which is why genetic counselling is offered to the whole family.

Other genes

MUTYH-associated polyposis, and rarer syndromes including Peutz-Jeghers and juvenile polyposis, each carry their own pattern and surveillance implications. Multi-gene panel testing is standard where testing is indicated, because testing only the best-known genes will miss some families.

Family history without a mutation

Having one first-degree relative with colorectal cancer raises risk; two affected relatives, or a relative diagnosed before 50, raises it further and justifies starting screening earlier, often around 40 or ten years before the youngest diagnosis in the family.

Inflammatory bowel disease

Long-standing ulcerative colitis and Crohn's disease involving the colon raise the risk of colorectal cancer, and the risk rises with the duration of disease and with the extent of colonic involvement. It is a different mechanism from the adenoma pathway: chronic inflammation itself predisposes to dysplasia, which is why surveillance in these patients begins earlier and is performed with targeted biopsies.

Control of inflammation is the mainstay of risk reduction in this group, and surveillance intervals depend on how long the disease has been present, how much of the colon is involved, whether there is associated primary sclerosing cholangitis, and whether dysplasia has been found previously. A patient with inflammatory bowel disease and a new change in bowel habit should be assessed rather than assumed to be having a flare.

What can actually be changed

This is the part of the page anyone can act on. None of these factors is a guarantee in either direction, and none of them means a person who develops colorectal cancer did something wrong.

Red and processed meat

High intake of red meat, and particularly processed meat, is associated with increased risk. Reducing consumption, and obtaining protein more often from fish, poultry, legumes and dairy, is a reasonable step with no downside worth weighing.

Alcohol and smoking

Both are associated with increased risk, and both are among the clearer modifiable factors in this disease. Smoking also raises the risk of recurrence and of death after a diagnosis, so stopping remains valuable at any point.

Body weight and activity

Higher body weight and physical inactivity are both associated with increased risk, and regular moderate activity is associated with lower risk. The effect is modest, and it is one of the few interventions with essentially no cost.

A caution about how this information is used. Dietary and lifestyle factors shift probabilities across populations, and they do not explain any individual case. Age, the adenoma pathway and inherited predisposition account for considerably more than diet does. The purpose of knowing the modifiable factors is to have something to act on — not to assign blame.

Other conditions and previous treatment

Type 2 diabetes and metabolic risk

Type 2 diabetes is associated with a moderately increased risk of colorectal cancer, as are obesity and a sedentary lifestyle. The mechanisms overlap with insulin resistance and chronic low-grade inflammation. This group is worth screening on schedule rather than being treated as exempt because the risk is "only" moderate.

Previous cancer treatment

Radiotherapy to the abdomen or pelvis raises the risk of a later colorectal cancer in the irradiated field, with a latency measured in years to decades. This applies to survivors of childhood and young-adult cancers in particular, and it justifies earlier and more frequent surveillance in that group.

Ethnic and geographic variation

Incidence differs substantially between populations, and rates in people who migrate tend to converge towards those of the host country within a generation or two — which is itself evidence that environment and diet contribute rather than genetics alone. This has practical relevance when assessing risk in patients born in countries with lower baseline incidence.

Cholecystectomy and other associations

Several weaker associations have been reported, including previous removal of the gallbladder and altered bile acid metabolism. These are of interest in understanding mechanisms and are not by themselves a reason for altered screening in an individual patient.

Things that are not risk factors

Several widely repeated claims have no good evidence behind them, and clearing them up frees attention for the factors that do matter.

Not supported by evidence

Occasional constipation as a cause of cancer; spicy food; coffee; and mobile phone use. Constipation and haemorrhoids are common reasons for delay in diagnosis, but neither causes the disease. A long-standing change in bowel habit deserves examination, not because constipation causes cancer but because the change may be the sign of it.

Worth distinguishing carefully

Screening tests do not "cause" cancer to spread, and a colonoscopy that finds nothing does not mean the test was unnecessary — it is the point of the test. Equally, removing a polyp does not eliminate future risk, which is why surveillance continues on a schedule after polyps have been removed.

What to do with this information

Risk factors are most useful when they become a specific plan. For most adults that means knowing the age at which to begin screening and at what interval. For some it means genetic testing, or earlier examination because of a family history or long-standing bowel disease.

If a relative has been diagnosed before 50, or if two relatives are affected, that pattern is worth a specific conversation rather than a generic one. Prevention and screening sets out what those plans consist of in practice, and symptoms and early warning signs covers what to do if something has already changed.

Frequently Asked Questions

Does a family history mean I will get colorectal cancer?

No. Most people with an affected relative never develop the disease, and most people who do develop it have no family history at all. What a family history changes is the surveillance plan — earlier and more frequent examination — and in some patterns it justifies genetic testing. The specific pattern matters: one relative diagnosed in their seventies carries a different implication from two relatives diagnosed in their forties, and it is worth describing the family history in detail rather than summarising it as positive or negative.

Should I be tested for Lynch syndrome?

Testing is worth discussing if you were diagnosed with colorectal cancer at a young age, if you have had more than one colorectal cancer or a colorectal cancer plus an endometrial or ovarian cancer, if your tumour is mismatch repair deficient, or if several relatives across generations have had colorectal, endometrial or urinary tract cancers. All colorectal cancers should in any case have mismatch repair or MSI testing on the tumour itself, because it identifies both the patients who may carry Lynch syndrome and those who may benefit from immunotherapy.

Can I reduce my risk by changing my diet?

Modestly. Limiting red and processed meat, limiting alcohol and not smoking, maintaining a healthy body weight and staying physically active are all associated with lower risk, and none of them guarantees anything in either direction. They are worth doing for those reasons and for the other health benefits — but none of them substitutes for screening. Removing a polyp at colonoscopy reduces risk by a greater margin than any dietary change, which is why screening remains the main measure in this disease.

I had polyps removed years ago. Does that matter now?

Yes, and it determines when your next examination should be. One or two small tubular adenomas carry a modestly raised risk and a shortened interval; advanced adenomas — large, villous, or with high-grade dysplasia — justify closer surveillance; multiple or repeatedly recurring adenomas raise the question of an inherited predisposition. The pathology report from that examination is worth obtaining, because the appropriate interval depends on the number, size and type of the polyps rather than on the fact that polyps were found.

Want your personal risk assessed?

Send your family history, any previous colonoscopy and pathology reports, and any genetic test results. Our colorectal team will return a written assessment of your risk profile and a recommended surveillance plan within 48 hours of the file being complete — with genetic counselling where it is indicated.

Want to see the whole process first? Your full medical journey, step by step →

Book an Appointment Request a Video Consultation

Follow Fosun Health

Apply for an Appointment

Do you have test results*